REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS
INDIAN DRUGS · 28.03.2026 · 63 (03) · 5-7
DOI: 10.53879/id.63.03.p0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift INDIAN DRUGS, online erschienen am 02.04.2026.
Abstract (Originalsprache)
Dear Reader, The year, 2026 and the month of March, 2026 is remarkably going down in history for multiple reasons and events. Oil and gas have taken the global news by storm with the war at Iran and gulf, while March 2026 has become most relevant for pharma industry, regulators and innovators for the flood-gates getting opened for weight-loss generics. The evolution of anti-obesity drugs has also highlighted the importance of pharmacovigilance as never before.
Zitieren
APA
(2026). REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS. INDIAN DRUGS, 63(03), 5-7. https://doi.org/10.53879/id.63.03.p0005
Vancouver
REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS. INDIAN DRUGS. 2026;63(03):5-7. doi:10.53879/id.63.03.p0005
BibTeX
@article{euvimed2026,
title = {REGULATORY AND INNOVATION HISTORY IN WEIGHT-LOSS GENERICS},
journal = {INDIAN DRUGS},
year = {2026},
volume = {63},
number = {03},
pages = {5--7},
doi = {10.53879/id.63.03.p0005}
}
EUVIMED